Issue 80, 2012

Development and characterization of an aptamer binding ligand of fractalkine using domain targeted SELEX

Abstract

Fractalkine (FKN) is a unique cell surface protein with potential as a therapeutic target because of its role in inflammatory diseases and cancer. We developed an aptamer, named FKN-S2, with a dissociation constant of 3.4 ± 0.7 nM that is specific to the chemokine domain of fractalkine.

Graphical abstract: Development and characterization of an aptamer binding ligand of fractalkine using domain targeted SELEX

Supplementary files

Article information

Article type
Communication
Submitted
13 Jun 2012
Accepted
19 Aug 2012
First published
31 Aug 2012

Chem. Commun., 2012,48, 10043-10045

Development and characterization of an aptamer binding ligand of fractalkine using domain targeted SELEX

B. Waybrant, T. R. Pearce, P. Wang, S. Sreevatsan and E. Kokkoli, Chem. Commun., 2012, 48, 10043 DOI: 10.1039/C2CC34217K

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements